B. Duhm

The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.

M. Kalipciyan, R. Mader, P. Högger, 2011, Clinical and experimental rheumatology.

A short-chain methotrexate polyglutamate as outcome parameter in rheumatoid arthritis patients receiving methotrexate.

B. Rizovski, R. Mader, P. Högger, 2012, Clinical and experimental rheumatology.

The pharmacokinetics of clotrimazole 14C.

W. Maul, B. Duhm, K. Patzschke, 1974, Postgraduate medical journal.

[Pharmacokinetics of bis-phenyl-(2-chloro-phenyl)-1-imidazolyl-methane-( 14 C) following topical administration].

W. Maul, B. Duhm, K. Patzschke, 1972, Arzneimittel-Forschung.

A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis.

R. Mader, P. Högger, B. Jilma, 2012, Clinical therapeutics.

Investigations on the pharmacokinetics of nifurtimox- 35 S in the rat and dog.

W. Maul, B. Duhm, K. Patzschke, 1972, Arzneimittel-Forschung.

[Animal experiments on pharmacokinetic and biotransformation of radioactively labelled 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester].

W. Maul, B. Duhm, K. Patzschke, 1972, Arzneimittel-Forschung.

[Experimental animal studies with alpha-methyldopa-14C, with special attention to the optical isomers. II. Organ distribution].

W. Maul, B. Duhm, K. Patzschke, 1967, Zeitschrift fur Naturforschung. Teil B, Chemie, Biochemie, Biophysik, Biologie und verwandte Gebiete.

Pharmacokinetics of Adalat in Animal Experiments

W. Maul, B. Duhm, K. Patzschke, 1975 .